Transcatheter Devices Market Size, Share, Growth Analysis, By Product(Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices, and Transcatheter Repair Devices), By Application(Cardiovascular, Oncology, Neurology, Urology), By Region - Industry Forecast 2024-2031

In October 2023, Laguna Tech USA accomplished effective clinical results in patients with aortic regurgitation using its Zeta balloon-expandable aortic valve system and Alpha self-expanding aortic valve system. As per a statement delivered on October 25, the US-based organization finished its first-in-human clinical case utilizing the Zeta system. Laguna likewise detailed the effective treatment of extra patients with its Alpha self-expanding aortic valve system in a practical study. Moreover, Laguna expressed that the device brought about the complete goal of aortic regurgitation in two patients, with supported results seen during a 30-day follow-up period.

In November 2023, Meril Life Sciences consented to a partnership agreement with Japan Lifeline to extend its worldwide presence. This strategic alliance grants Japan Lifeline elite rights to advance Meril's Transcatheter Heart Valve, Myval Octacor, when it gets PMD approval in Japan.

In November 2023, Anteris Technologies Ltd CEO Wayne Paterson imparted to Proactive about finishing enlistment for the company's early feasibility study (EFS) for DurAVR™ THV. This creative device, the world's only balloon-expandable, single-piece transcatheter aortic valve, is going through testing to treat 15 patients with indicative, extreme native aortic stenosis. The review is vital for acquiring freedom from the US Food and Drug Administration (FDA).